Patients No return to the status quo: Why now is the time for value-b... Value-based, person-centred healthcare is the key to system resilience – and now is the time to make it happen.
News Could a vaccine adjuvant be protective against dementia? Scientists behind a study suggesting GSK's RSV vaccine may be protective against dementia have said the adjuvant used in it may be responsible.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
